Your browser doesn't support javascript.
loading
Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
Gökbuget, Nicola; Boissel, Nicolas; Chiaretti, Sabina; Dombret, Hervé; Doubek, Michael; Fielding, Adele; Foà, Robin; Giebel, Sebastian; Hoelzer, Dieter; Hunault, Mathilde; Marks, David I; Martinelli, Giovanni; Ottmann, Oliver; Rijneveld, Anita; Rousselot, Philippe; Ribera, Josep; Bassan, Renato.
  • Gökbuget N; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Boissel N; Hospital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Chiaretti S; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Dombret H; Leukemia Department, University Hospital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Saint-Louis Research Institute, Université Paris Cité, Paris, France.
  • Doubek M; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Fielding A; UCL Cancer Institute, London, United Kingdom.
  • Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Hoelzer D; Department of Medicine II, Hematology/Oncology, Goethe University, University Hospital, Frankfurt, Germany.
  • Hunault M; Maladies du Sang University Hospital of Angers, FHU Goal, INSERM, National Centre for Scientific Research, Angers, France.
  • Marks DI; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
  • Martinelli G; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy.
  • Ottmann O; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Rijneveld A; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Rousselot P; Clinical Hematology Department, Centre Hospitalier de Versailles, Université Paris-Saclay, Versailles, France.
  • Ribera J; Clinical Hematology Department, Institut Catala d'Oncologia Hospital Germans Trias I Pujol, Josep Carreras Research Institute, Badalona, Spain.
  • Bassan R; Division of Hematology, Ospedale dell'Angelo, Mestre-Venice, Italy.
Blood ; 143(19): 1903-1930, 2024 May 09.
Article en En | MEDLINE | ID: mdl-38306595
ABSTRACT
ABSTRACT Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Humans País como asunto: Europa Idioma: En Año: 2024 Tipo del documento: Article